| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | Director | Common Stock | 31,299 | $2.62 M | $83.81 | Mar 18, 2024 | Direct |
| BIOMARIN PHARMACEUTICAL INC | Director | Stock Option (Right to Buy Common Stock) | 0 | Mar 18, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | Mar 18, 2024 | 3 | -33 | 4 | Mar 20, 2024 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 23, 2023 | 1 | 0 | 4 | May 24, 2023 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 24, 2022 | 1 | 0 | 4 | May 26, 2022 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | Feb 28, 2022 | 6 | -501,013 | 4 | Mar 2, 2022 | Director |
| BMRN | BIOMARIN PHARMACEUTICAL INC | May 25, 2021 | 1 | 0 | 4 | May 27, 2021 | Director |